Prevalence of Skin-specific Autoantibodies in HIV-infected Patients and Uninfected Controls

• Main Authors: Veronique Touzeau-Roemer (Author), Michael Skoll (Author), Pooja Tajpara (Author), Philip Kienzl (Author), Antonia Wesinger (Author), Simona Saluzzo (Author), Martin Bauer (Author), Maximilian C. Aichelburg (Author), Christine Bangert (Author), Wolfgang Bauer (Author), Georg Stingl (Author), Armin Rieger (Author), Katharina Grabmeier-Pfistershammer (Author), Christopher Schuster (Author)
• Format: Book
• Published: Medical Journals Sweden, 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 0001-5555; 1651-2057; 10.2340/00015555-3251
• Keywords: HIV; autoimmune blistering skin disease; bullous pemphigoid; pemphigus; cART; Dermatology; RL1-803
• Source: Acta Dermato-Venereologica, Vol 99, Iss 11, Pp 978-983 (2019)

Various autoantibodies are detected more frequently in HIV-infected individuals than in HIV-negative controls; however, limited data exist regarding autoimmune blistering skin diseases. Using enzyme-linked immunoassay (ELISA) and indirect immunofluore­scence, no difference in the frequency and magnitude of autoantibodies against BP180, BP230, desmoglein 1 and 3 was found between 594 HIV-infected patients and 248 uninfected controls in this cross-sectional study (16.0% vs. 11.7%, respectively, for at least one positive ELISA, p = 0.11). Interestingly, reactive syphilis serology in both HIV-infected individuals and uninfected controls was associated with positive anti-BP180 ELISA results (adjusted odds ratio (OR) 2.14, 95% confidence interval (CI) 1.07-4.29, p = 0.03 and OR 4.70, CI 1.3-16.86; p = 0.0180). Our study shows a comparably low prevalence of cutaneous autoantibodies in both HIV-infected patients and uninfected controls lacking signs of autoimmune blistering skin disease. Positive BP180 ELISA in the absence of clinical signs of bullous pemphigoid should prompt further evaluation for syphilis antibodies.